Right Amarantus Acquires Exclusive Option to Li
Post# of 30028
Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity
http://www.globenewswire.com/news-release/201...ml?print=1